These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17252984)

  • 1. [Character of patients with paroxysmal atrial fibrillation].
    Kogut P; Banach T; Bonior J; Zarow R
    Folia Med Cracov; 2005; 46(3-4):3-11. PubMed ID: 17252984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel explanation for the cause of atrial fibrillation seen in atherosclerotic coronary artery disease: "downstream inflammation" hypothesis.
    Güvenç TS; Ilhan E; Hasdemir H; Satilmiş S; Alper AT
    Med Hypotheses; 2010 Apr; 74(4):665-7. PubMed ID: 19962248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac arrhythmias: management of atrial fibrillation in the critically ill patient.
    Crawford TC; Oral H
    Crit Care Clin; 2007 Oct; 23(4):855-72, vii. PubMed ID: 17964366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of stabilized and paroxysmal atrial fibrillation].
    Kotulski J
    Wiad Lek; 1982 Jun; 35(7-8):445-50. PubMed ID: 7123935
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial fibrillation: an increasingly common and provocative arrhythmia.
    Futterman LG; Lemberg L
    Am J Crit Care; 1996 Sep; 5(5):379-87. PubMed ID: 8870863
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation.
    Sloan RW; Zervanos NJ; Snyder RL; Zurad EG
    J Fam Pract; 1986 Jan; 22(1):25-7, 30-4, 36. PubMed ID: 3941299
    [No Abstract]   [Full Text] [Related]  

  • 8. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal atrial fibrillation. A common but neglected entity.
    Aboaf AP; Wolf PS
    Arch Intern Med; 1996 Feb; 156(4):362-7. PubMed ID: 8607721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is quinidine an outmoded drug?].
    Goldmann R; Folwarczny S; Skrízalová A; Pieniazková V
    Vnitr Lek; 1997 Apr; 43(4):217-20. PubMed ID: 9601839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic atrial fibrillation in adults: direct current cardioversion or medical cardioversion].
    Fradi I; Mokaddem A; Selmi K; Boujnah MR
    Tunis Med; 2006 Dec; 84(12):772-6. PubMed ID: 17288278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery.
    Lin JA; Borel CO; Wang WB; Wong CS; Yeh CC; Yang CP; Wu CT
    J Clin Anesth; 2006 Aug; 18(5):372-5. PubMed ID: 16905084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension.
    Hennersdorf MG; Schueller PO; Steiner S; Strauer BE
    Hypertens Res; 2007 Jun; 30(6):535-40. PubMed ID: 17664857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinidine rehabilitated and more lessons from the PAFAC and SOPAT anti-arrhythmic drug trials for the prevention of paroxysmal atrial fibrillation.
    van Hemel N
    Eur Heart J; 2004 Aug; 25(16):1371-3. PubMed ID: 15321693
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
    Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
    Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey.
    de Vos CB; Nieuwlaat R; Crijns HJ; Camm AJ; LeHeuzey JY; Kirchhof CJ; Capucci A; Breithardt G; Vardas PE; Pisters R; Tieleman RG
    Eur Heart J; 2008 Mar; 29(5):632-9. PubMed ID: 18270212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxysmal atrial fibrillation: which patients need anti-arrhythmia drugs?. Interview by Dr. med. Ulrike Hennemann].
    Meinertz T
    Fortschr Med; 1996 Aug; 114(24):42-3. PubMed ID: 8974971
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxysmal atrial fibrillation and health-related quality of life: the importance of keeping score.
    Aves T; Dorian P
    Europace; 2010 May; 12(5):606-7. PubMed ID: 20228396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.